Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (1031-1040 of 1,158) with videos related to

Pageof 116
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|December 27, 2019
Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Kuniaki Takahashi, et al.
Journal of the American College of Cardiology|November 4, 2017
Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST RegistryKyohei Yamaji, Yasushi Ueki, Geraud Souteyrand, et al.
BMJ (Clinical Research Ed.)|June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Journal of the American College of Cardiology|February 8, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary InterventionsFelice Gragnano, Roxana Mehran, Mattia Branca, et al.
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
The New England Journal of Medicine|October 31, 2017
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic ShockHolger Thiele, Ibrahim Akin, Marcus Sandri, et al.
International Journal of Cardiology|March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, David van Klaveren, et al.
European Journal of Preventive Cardiology|August 12, 2025
Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement: association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trialVera van der Velpen, Jonas D Häner, Ryota Kakizaki, et al.
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Pageof 116

Showing results (1031-1040 of 1,158) with videos related to

Sort By:
Pageof 116
European Heart Journal. Cardiovascular Pharmacotherapy|December 27, 2019
Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Kuniaki Takahashi, et al.
Journal of the American College of Cardiology|November 4, 2017
Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST RegistryKyohei Yamaji, Yasushi Ueki, Geraud Souteyrand, et al.
BMJ (Clinical Research Ed.)|June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Journal of the American College of Cardiology|February 8, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary InterventionsFelice Gragnano, Roxana Mehran, Mattia Branca, et al.
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
The New England Journal of Medicine|October 31, 2017
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic ShockHolger Thiele, Ibrahim Akin, Marcus Sandri, et al.
International Journal of Cardiology|March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, David van Klaveren, et al.
European Journal of Preventive Cardiology|August 12, 2025
Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement: association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trialVera van der Velpen, Jonas D Häner, Ryota Kakizaki, et al.
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Pageof 116